Strontium binding by calcium silicate hydrates.

J Colloid Interface Sci

Laboratory for Waste Management, Nuclear Energy and Safety Research Department, Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland.

Published: August 2006

In the present study the binding of strontium with pure calcium silicate hydrates (C-S-H) has been investigated using batch-type experiments. Synthetic C-S-H phases with varying CaO:SiO(2) (C:S) mol ratios, relevant to non-degraded and degraded hardened cement paste, were prepared in the absence of alkalis (Na(I), K(I)) and in an alkali-rich artificial cement pore water (ACW). Two types of experimental approaches have been employed, investigating sorption and co-precipitation processes, respectively. The Sr(II) sorption kinetics were determined as well as sorption isotherms, the effect of the solid to liquid ratio and the composition (C:S ratio) of the C-S-H phases. In addition, the reversibility of the Sr(II) sorption was tested. It was shown that both the sorption and co-precipitation tests resulted in Sr(II) distribution ratios which were similar in value, indicating that the same sites are involved in Sr(II) binding. In alkali-free solutions, the Sr(II) uptake by C-S-H phases was described in terms of a Sr(2+)-Ca(2+) ion exchange model. The selectivity coefficient for the Sr(2+)-Ca(2+) exchange was determined to be 1.2+/-0.3.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcis.2006.03.043DOI Listing

Publication Analysis

Top Keywords

c-s-h phases
12
calcium silicate
8
silicate hydrates
8
sorption co-precipitation
8
srii sorption
8
sorption
5
srii
5
strontium binding
4
binding calcium
4
hydrates study
4

Similar Publications

Construction of a Molecular Dynamics Model of N-A-S-H Geopolymer Based on XRD Analysis.

Materials (Basel)

December 2024

College of Materials Science and Engineering, Shenyang Jianzhu University, Shenyang 110168, China.

A geopolymer is a low-carbon cementitious material, and its condensation process is akin to the formation of inorganic polymers. The crystal phase of synthesized geopolymers was identified using XRD; the scattering peaks of amorphous phases were analyzed, and the zeolite minerals akin to different n(Si)/n(Al) geopolymers were determined. Based on this, a model structure of N-A-S-H geopolymers was established.

View Article and Find Full Text PDF

Hydration and carbonation curing of high ferrite clinker (FePC) synthesized using EAF slag.

Low Carbon Mater Green Constr

December 2024

Faculty of Technology, Fiber and Particle Engineering Research Unit, University of Oulu, PO Box 4300, 90014 Oulu, Finland.

Unlabelled: This study explores the use of Electric Arc Furnace (EAF) slag as a sustainable alternative raw material in cement clinker production. The research demonstrates the synthesis of ferrite-rich clinker using EAF slag, achieving a clinker composition of 47% alite, 32% ferrite, and 20% belite while replacing 20% of clinker raw materials i.e.

View Article and Find Full Text PDF

Imlunestrant with or without Abemaciclib in Advanced Breast Cancer.

N Engl J Med

December 2024

From Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (K.L.J.); University Hospitals Leuven, Leuven, Belgium (P.N.); Hospital María Curie, Buenos Aires (M.L.C.); Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.-B.K.); National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan (E.T.); Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Brussels (P.A.); Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona (C.S.); Baylor University Medical Center, Texas Oncology, U.S. Oncology, Dallas (J.O.); the Breast Center, Department of Obstetrics and Gynecology and Comprehensive Cancer Center Munich, Ludwig Maximilians University Munich University Hospital, Munich, Germany (N.H.); the University of North Carolina at Chapel Hill, Chapel Hill (L.A.C.); the University of Milan, Milan (G.C.); the European Institute of Oncology, IRCCS, Milan (G.C.); Hospital Arnau de Vilanova, Valencia, Spain (A.L.-C.); Garvan Institute of Medical Research and University of New South Wales, Sydney (E.L.); Hospital de Oncología, Centro Médico Nacional Siglo XXI, Mexico City (M.L.G.T.); Yonsei University College of Medicine, Seoul, South Korea (J.S.); the Mastology Department, Women's Health Hospital, São Paulo (A.M.); Harbin Medical University Cancer Hospital, Harbin, China (Q.Z.); National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei (C.-S.H.); the Division of Breast Surgery, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan (C.-C.H.); Filios Alta Medicina, Monterrey, Mexico (J.L.M.R.); the Medical Oncology Department, Hospital Universitario Virgen del Rocío, Seville, Spain (M.R.B.); the Department of Breast Surgery, Chiba Cancer Center Hospital, Chiba, Japan (R.N.); Eli Lilly, Indianapolis (K.R.P., C.C.L., E.B., S.C., X.A.W., L.M.S.); and Institut Curie and University of Versailles Saint-Quentin-en-Yvelines-Paris-Saclay University, Paris (F.-C.B.).

Background: Imlunestrant is a next-generation, brain-penetrant, oral selective estrogen-receptor (ER) degrader that delivers continuous ER inhibition, even in cancers with mutations in the gene encoding ERα ().

Methods: In a phase 3, open-label trial, we enrolled patients with ER-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer that recurred or progressed during or after aromatase inhibitor therapy, administered alone or with a cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor. Patients were assigned in a 1:1:1 ratio to receive imlunestrant, standard endocrine monotherapy, or imlunestrant-abemaciclib.

View Article and Find Full Text PDF

Neuroplasticity therapy using glia-like cells derived from human mesenchymal stem cells for the recovery of cerebral infarction sequelae.

Mol Ther

November 2024

Laboratory of Stem Cell & Neurobiology, Department of Oral Anatomy and Dental Research Institute, Seoul National University School of Dentistry, Seoul 03080, Republic of Korea; Interdisciplinary Program in Neuroscience, Seoul National University College of Natural Sciences, Seoul 08826, Republic of Korea; Neuroscience Research Institute, Seoul National University, Seoul 03080, Republic of Korea. Electronic address:

Article Synopsis
  • This study explores using human mesenchymal stem cells (hMSCs) transformed into glia-like cells (ghMSCs) to improve recovery after ischemic strokes, which cause brain damage.
  • Transcriptome analysis shows that ghMSCs behave like astrocytes and demonstrate better protective and regenerative qualities against brain injury than regular hMSCs.
  • In rat models, transplanting ghMSCs improved behavioral function and reduced brain damage, with their effectiveness linked to CXCR2 signaling, suggesting a potential therapy for stroke recovery by promoting neuroplasticity.
View Article and Find Full Text PDF

The rice husk biomass remaining from the industrial processing of rice constitutes approximately 25 wt% of the edible rice produced, and its disposal is challenging due to its high silica content. Here, we describe the optimization of a single step innovative chemical process for the conversion of rice husk-based biomass into useable products which tackles all fractions of the input biomass. The chemical process consists of a single step hydrothermal low temperature treatment of rice husk biomass leading to three easy-to-recover fractions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!